Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 7, 2012, Pages 1749-1754

  Pérez Cardona, Pablo S Corona ^a   Ojeda, Victor Barro ^a   Pardo, Dolors Rodriguez ^a   Serrallach, Carlos Pigrau ^a   Farfán, Ernesto Guerra ^a   Mateu, Carles Amat ^a   Sanchez, Xavier Flores ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Adverse reactions; Antibiotic therapy; Arthroplasty; Device related infections; Treatment outcome

Indexed keywords

DAPTOMYCIN; LINEZOLID; METHYLPREDNISOLONE; RIFAMPICIN; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIUM CULTURE; CLINICAL ARTICLE; COXITIS; CREATINE KINASE BLOOD LEVEL; DEBRIDEMENT; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FEVER; FOLLOW UP; HUMAN; KNEE DISEASE; LOEFFLER PNEUMONIA; LUNG LAVAGE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MUSCLE WEAKNESS; PERIPROSTHETIC JOINT INFECTION; POSTOPERATIVE CARE; RETROSPECTIVE STUDY; RHABDOMYOLYSIS; SALVAGE THERAPY; SIDE EFFECT; SURGICAL APPROACH; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DAPTOMYCIN; DRUG TOXICITY; FEMALE; HIP PROSTHESIS; HUMANS; KNEE PROSTHESIS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84862648677     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks119     Document Type: Article

References (30)

1. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351: 1645-54.
2. Cataldo MA, Petrosillo N, Cipriani M et al. Prosthetic joint infection: recent developments in diagnosis and management. J Infect 2010; 61: 443-8.
3. Costerton JW. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res 2005; 437: 7-11.
4. Tsukayama DT, Goldberg VM, Kyle R. Diagnosis and management of infection after total knee arthroplasty. J Bone Joint Surg Am 2003; 85-A Suppl 1: S75-80.
5. Falagas ME, Giannopoulou KP, Ntziora F et al. Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence. Int J Antimicrob Agents 2007; 30: 202-9.
6. Salgado CD, Dash S, Cantey JR et al. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 2007; 461: 48-53.
7. Rice DA, Mendez-Vigo L. Daptomycin in bone and joint infections: a review of the literature. Arch Orthop Trauma Surg 2009; 129: 1495-504.
8. Finney MS, Crank CW, Segreti J. Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections. Curr Med Res Opin 2005; 21: 1923-6.
9. Appelbaum PC. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2007; 30: 398-408.
10. Barry AL, Fuchs PC, Brown SD. In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers. Antimicrob Agents Chemother 2001; 45: 1919-22.
11. Carpenter CF, Chambers HF. Daptomycin: another novel agent for treating infections due to drug-resistant Gram-positive pathogens. Clin Infect Dis 2004; 38: 994-1000.
12. Rao N, Regalla DM. Uncertain efficacy of daptomycin for prosthetic joint infections. A prospective case series. Clin Orthop Relat Res 2006; 451: 34-7.
13. Leite B, Gomes F, Teixeira P et al. In vitro activity of daptomycin, linezolid and rifampicin on Staphylococcus epidermidis biofilms. Curr Microbiol 2011; 63: 313-7.
14. Smith K, Perez A, Ramage G et al. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilm to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents 2009; 33: 374-8.
15. Corona P, Gil E, Guerra E et al. Percutaneous interface biopsy in dry-aspiration cases of chronic periprosthetic joint infections: a technique for preoperative isolation of the infecting organism. Int Orthop 2011; doi:10.1007/s00264-011-1418-0.
16. Bradbury T, Fehring TK, Tauton M et al. The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J Arthroplasty 2009; 24 Suppl: 101-4.
17. Poeppl W, Tobudic S, Lingscheid T et al. Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model. Antimicrob Agents Chemother 2011; 55: 4999-5003.
18. Antony SJ, Angelos E, Stratton CW. Clinical experience with daptomycin in patients with orthopedic related infections. Infect Dis Clin Pract 2006; 14: 144-9.
19. Garrigós C, Murillo O, Euba G et al. Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010; 54: 5251-6.
20. Kullar R, Davis SL, Levine DP et al. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy 2011; 31: 527-36.
21. Figueroa DA, Mangini E, Amodio-Groton M et al. Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program. Clin Infect Dis 2009; 49: 177-80.
22. Saleh-Mghir A, Muller-Serieys C, Dinh A et al. Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2011; 55: 4589-93.
23. John AK, Baldoni D, Haschke M et al. Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother 2009; 53: 2719-24.
24. Deirmengian C, Greenbaum J, Lotke PA et al. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. J Arthroplasty 2003; 18 Suppl 1: 22-6.
25. Hair PI, Keam SJ. Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia. Drugs 2007; 67: 1483-512.
26. Kazory A, Dibadj K, Weiner ID. Rhabdomyolysis and acute renal failure in a patient treated with daptomycin. J Antimicrob Chemother 2006; 57: 578-9.
27. Papadopoulos S, Ball AM, Liewer SE et al. Rhabdomyolysis during therapy with daptomycin. Clin Infect Dis 2006; 42: e108-10.
28. Miller BA, Gray A, Leblanc TW et al. Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases. Clin Infect Dis 2010; 50: e63-8.
29. Antony SJ, Tiscareno-Grajeda I, Misenhiemer G et al. Use of daptomycin in the treatment of prosthetic joint infections: a prospective observational study of 30 patients with infected prosthetic joint infections. The Internet Journal of Infectious Diseases 2009; Volume 7, Number 1.
30. Licitra CM, Crespo A, Licitra D et al. Daptomycin for the treatment of osteomyelitis and prosthetic joint infection: retrospective analysis of efficacy and safety in an outpatient infusion center. The Internet Journal of Infectious Diseases 2011; Volume 9, Number 2.